Ora

What is VLCAD?

Published in Fatty Acid Oxidation Disorder 2 mins read

VLCAD, which stands for Very Long Chain Acyl-CoA Dehydrogenase deficiency, is a rare genetic metabolic disorder. It is a type of fatty acid oxidation disorder that affects the body's ability to convert certain types of fats into energy.

Understanding VLCAD

For the body to function, it needs energy, which it primarily obtains from breaking down food. Fats are an important source of this energy, especially during times when the body isn't actively eating, such as overnight or during periods of illness or fasting.

People with VLCAD cannot effectively break down very long chain fatty acids—a specific type of fat—into usable energy. This means that these fats can accumulate in the body while the body struggles to produce the necessary energy.

What Causes VLCAD?

VLCAD occurs due to a problem with a specific enzyme. Enzymes are proteins that act as catalysts, helping to start and speed up chemical reactions within the body, including those involved in breaking down fats into energy.

Specifically, VLCAD happens when the enzyme called "very long chain acyl-CoA dehydrogenase" is either:

  • Missing: The body does not produce this enzyme at all.
  • Not working properly: The enzyme is present but is not functioning as it should.

Without a functional very long chain acyl-CoA dehydrogenase enzyme, the body cannot properly process very long chain fatty acids, leading to the metabolic issues characteristic of VLCAD.

Key Aspects of VLCAD

To summarize the essential information about VLCAD:

Aspect Description
What it is A rare genetic metabolic disorder, specifically a type of fatty acid oxidation disorder.
Impact Impairs the body's ability to break down certain types of fat (very long chain fatty acids) into energy.
Cause Deficiency or malfunction of the "very long chain acyl-CoA dehydrogenase" enzyme.
Mechanism Prevents the proper conversion of very long chain fats into energy, leading to their accumulation.

Understanding VLCAD is crucial for early diagnosis and management, which can significantly improve outcomes for affected individuals.